33 related articles for article (PubMed ID: 6202101)
1. Indole Derivatives Obtained from Egyptian
Amer MA; Wasfi R; Attia AS; Ramadan MA
Antibiotics (Basel); 2021 Mar; 10(4):. PubMed ID: 33805493
[No Abstract] [Full Text] [Related]
2. Overview of
Chakkour M; Hammoud Z; Farhat S; El Roz A; Ezzeddine Z; Ghssein G
Front Microbiol; 2024; 15():1383618. PubMed ID: 38646633
[No Abstract] [Full Text] [Related]
3. Pathogenic Factors Correlate With Antimicrobial Resistance Among Clinical
Filipiak A; Chrapek M; Literacka E; Wawszczak M; Głuszek S; Majchrzak M; Wróbel G; Łysek-Gładysińska M; Gniadkowski M; Adamus-Białek W
Front Microbiol; 2020; 11():579389. PubMed ID: 33324365
[No Abstract] [Full Text] [Related]
4. Molecular Analysis of Virulence Genes HpmB and rsbA among
Mathlum Al-Khafaji K; Ayyal Mutar Alrashedi A; Al-Rubaeaee AA
Arch Razi Inst; 2023 Aug; 78(4):1295-1303. PubMed ID: 38226368
[No Abstract] [Full Text] [Related]
5. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.
Jacobsen SM; Stickler DJ; Mobley HL; Shirtliff ME
Clin Microbiol Rev; 2008 Jan; 21(1):26-59. PubMed ID: 18202436
[TBL] [Abstract][Full Text] [Related]
6. Potential virulence factors of Proteus bacilli.
Rózalski A; Sidorczyk Z; Kotełko K
Microbiol Mol Biol Rev; 1997 Mar; 61(1):65-89. PubMed ID: 9106365
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic activity and invasiveness in strains of Proteus penneri.
Rozalski A; Kotełko K
J Clin Microbiol; 1987 Jun; 25(6):1094-6. PubMed ID: 3597752
[TBL] [Abstract][Full Text] [Related]
8. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
Mobley HL; Island MD; Massad G
Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
[TBL] [Abstract][Full Text] [Related]
9. Swarmer cell differentiation in Proteus mirabilis.
Rather PN
Environ Microbiol; 2005 Aug; 7(8):1065-73. PubMed ID: 16011745
[TBL] [Abstract][Full Text] [Related]
10. Some biological features of Proteus bacilli. 1. Comparison of Proteus mirabilis strains provided from various sources.
Kotelko K; Rozalski A; Deka M; Kaca W; Sidorczyk Z; Gromska W; Zych K
Acta Microbiol Pol; 1983; 32(4):339-44. PubMed ID: 6202101
[TBL] [Abstract][Full Text] [Related]
11. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
Kotelko K; Kaca W; Rózalski A; Deka M
Acta Microbiol Pol; 1983; 32(4):345-51. PubMed ID: 6202102
[TBL] [Abstract][Full Text] [Related]
12. Some biological features of proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains.
Rózalski A; Wykrota M
Acta Microbiol Pol; 1986; 35(1-2):57-9. PubMed ID: 2426926
[TBL] [Abstract][Full Text] [Related]
13. Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis--an explanation.
Senior BW
J Med Microbiol; 1983 Aug; 16(3):317-22. PubMed ID: 6348289
[TBL] [Abstract][Full Text] [Related]
14. Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine.
Peerbooms PG; Verweij AM; Oe PL; MacLaren DM
Antonie Van Leeuwenhoek; 1986; 52(1):53-62. PubMed ID: 3524444
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]